Department of Regulatory Affairs and Drug Evaluation, Tokyo Biomedical University, Japan
Opinion
Advancing Drug Safety, Development, and Patient Care
Author(s): Kenji Yamamoto*
DOI:
10.37421/2167-7689.2025.14.503
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 